Scientists have developed a breakthrough phospholipid complex that enhances CBD absorption, improving its therapeutic ...

Detailed price information for Cardiol Therapeutics (CRDL-Q) from The Globe and Mail including charting and trades.

Analysts have recently evaluated Harmony Biosciences Hldgs and provided 12-month price targets. The average target is $58.0, ...

and cannabidiol (CBD). In the old days, the original plant had about two molecules of THC for every single molecule of CBD. Today, that ratio is vastly different; thus, interpreting older studies ...

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory ...

The company's product WAKIX (pitolisant) is a molecule with a novel mechanism ... BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX ...

Cannabidiol or CBD is not intoxicating ... It's a common misconception, and alcohol is a single molecule. Cannabis, as I mentioned, is a really complex plant, and there are over 400 compounds ...

The company's product WAKIX (pitolisant) is a molecule with a novel mechanism ... BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX ...

Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through its proprietary small molecule platform, Cerebrum ...

Isomyosamine is a drug platform based on a clinical stage small molecule that regulates the ... Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address ...